Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Kedudukan dalam Saham #17922
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Harga Saham
$18.20
Disegerakkan terakhir: 2025-05-09
Modal Pasaran
$220.35M
Perubahan (1 hari)
-5.34%
Perubahan (1 tahun)
0.00%
Negara
JP
Perdagangan I'rom Group Co., Ltd. (2372)

Kategori

Hasil untuk I'rom Group Co., Ltd. (2372)
Hasil pada Dec 2024 TTM: $119.61M
Menurut laporan kewangan terkini daripada I'rom Group Co., Ltd., hasil semasa syarikat (TTM) ialah $119.61M. Pada tahun 2023, syarikat memperoleh hasil sebanyak $138.21M peningkatan berbanding hasil pada tahun 2022 iaitu $128.89M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi I'rom Group Co., Ltd. dari 2005 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $119.61M 2.05%
2024 $117.21M -15.20%
2023 $138.21M 7.24%
2022 $128.89M 10.61%
2021 $116.52M 18.27%
2020 $98.53M 3.39%
2019 $95.30M 17.45%
2018 $81.14M 84.82%
2017 $43.90M 20.07%
2016 $36.56M 6.08%
2015 $34.47M -11.37%
2014 $38.89M -45.34%
2013 $71.14M -46.43%
2012 $132.81M -21.31%
2011 $168.78M 14.16%
2010 $147.85M 0.49%
2009 $147.13M 6.89%
2008 $137.65M 9.43%
2007 $125.78M 16.35%
2006 $108.10M 100.44%
2005 $53.93M 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$78.01B 65,123.26%
US
- -
DE
$3.89B 3,156.35%
SA
$21.81B 18,136.06%
US
- -
MY